Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.

@article{Lu2019AllostericMD,
  title={Allosteric Modulator Discovery: From Serendipity to Structure-Based Design.},
  author={Shaoyong Lu and Xin-heng He and D. Ni and Jian Zhang},
  journal={Journal of medicinal chemistry},
  year={2019}
}
Allosteric modulators bound to structurally diverse allosteric sites can achieve better pharmacological advantages than orthosteric ligands. The discovery of allosteric modulators, however, has been traditionally serendipitous, owing to the complex nature of allosteric modulation. Recent advances in the understanding of allosteric regulatory mechanisms and remarkable availability of structural data of allosteric proteins and modulators, as well as their complexes, have greatly contributed to… 
Rational design of allosteric modulators: Challenges and successes
TLDR
The future of rational allosteric ligand design with newly built computational tools that are expected to be applied in future studies are presented, concluding to theoretical and practical guidelines for allosterIC ligandDesign strategies and identify knowledge gaps that need to be addressed to improve efficiency in allosteri drug design.
Harnessing Reversed Allosteric Communication: A Novel Strategy for Allosteric Drug Discovery.
TLDR
The latest research on the reversed allosteric communication effect is reviewed using the examples of sirtuin 6, epidermal growth factor receptor, 3-phosphoinositide-dependent protein kinase 1, and Related to A and C kinases (RAC) serine/threonineprotein kinase B to recapitulate the methodologies of reversed allostery communication strategy.
Discovery of cryptic allosteric sites using reversed allosteric communication by a combined computational and experimental strategy
TLDR
This study proposed a state-of-the-art computational pipeline for detecting allosteric sites based on reversedallosteric communication, which enabled the identification of a previously uncharacterized potential crypticAllosteric site on Sirt6, which provides a starting point for allostero-drug design that can aid the Identification of candidate pockets in other therapeutic targets.
Along the allostery stream: Recent advances in computational methods for allosteric drug discovery
TLDR
In this review, recent advances in computational methods applied to allosteric drug discovery are summarized and comprehensively review these achievements along various levels ofallosteric events, from the construction of allosterics databases to the identification and analysis ofAllosteric residues, signals, sites, and modulators.
Integrated Computational Approaches and Tools for Allosteric Drug Discovery
TLDR
Computational approaches for allosteric drug discovery are reviewed and how these tools can be utilized to develop consensus workflows for in silico identification ofallosteric sites and modulators with some applications to pathogen resistance and precision medicine are discussed.
Recent Advances in the Discovery of CK2 Allosteric Inhibitors: From Traditional Screening to Structure-Based Design
TLDR
This study summarizes the recent advances in the identification of CK2 allosteric inhibitors and presents the well-elucidated allosterIC sites, which are expected to provide valuable clues for the design of CK1 allosterics inhibitors.
Unraveling allosteric landscapes of allosterome with ASD
TLDR
Over the past ten years, the Allosteric Database has become a central resource for studying allosteric regulation and will play more important roles in both target identification andallosteric drug discovery in the future.
...
...

References

SHOWING 1-10 OF 211 REFERENCES
Harnessing Allostery: A Novel Approach to Drug Discovery
TLDR
In the present review, the recent advances in the repertoire of allostery are summarized, with a particular focus on the aforementioned allosteric compounds.
Improved Method for the Identification and Validation of Allosteric Sites.
TLDR
The AllositePro method is presented, a method which predicts allosteric sites in proteins by combining pocket features with perturbation analysis and is superior to that of the other currently available methods.
Are the Apo Proteins Suitable for the Rational Discovery of Allosteric Drugs?
TLDR
Large-scale conformational samplings of six representative allosteric proteins uncomplexed and complexed with orthosteric ligands indicated that Orthosteric site binding had an effect on the dynamics of the allosteri sites andallosteric modulators preferentially bound to their holo proteins, highlighting the strong demand to select holo allosterics proteins as initial inputs in structure-based allosterIC drug screening.
Emerging Computational Methods for the Rational Discovery of Allosteric Drugs
TLDR
Algorithms that predict allosteric sites based on sequence data and molecular dynamics simulations are reviewed, tools that assess the druggability of these pockets are described, and how Markov state models and topology analyses provide insight into the relationship between protein dynamics andallosteric drug binding are discussed.
Emerging paradigms in GPCR allostery: implications for drug discovery
TLDR
New findings have the potential to alter how screening for allosteric drugs is performed and may increase the chances of success in the development ofallosteric modulators as clinical lead compounds.
Reversing allosteric communication: From detecting allosteric sites to inducing and tuning targeted allosteric response
TLDR
This work validate the “reverse perturbation” hypothesis and its predictive power on a set of classical allosteric proteins, then, on the independent extended benchmark set, and shows that, in addition to knownallosteric sites, the perturbations of the functional sites unravels rather extended protein regions, which can host latent regulatory exosites.
Drugs for allosteric sites on receptors.
TLDR
The presence of druggable, topographically distinct allosteric sites on a wide range of receptor families has offered new paradigms for small molecules to modulate receptor function and key principles and strategies have emerged for the design of ligands/drugs for allosterIC sites.
...
...